Exploring characteristics of haemodialysis patients related to successful individual application of bioimpedance to help determine the endpoint of dialysis treatment

• Conditions: End-stage renal disease; kidney disease; 10038430

• Registration Number: NL-OMON46424
• Lead Sponsor: Wageningen Universiteit

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 120

Inclusion Criteria

ESRD patients undergoing intermittent daytime haemodialysis treatment at Ziekenhuis Gelderse Vallei in Ede
Undergoing routine HD treatment for at least three months

Exclusion Criteria

Pacemaker
Metal implants
Major amputations
Pregnancy
Restless legs
Dementia

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary endpoint constitutes whether BIA can be successfully used to<br /><br>determine the endpoint of HD treatment. *Success* is hereby defined as post-HD<br /><br>normovolemia as assessed by BIA.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary parameters include nutritional status, body composition, and the<br /><br>presence of comorbidities.</p><br>